Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease.
Huntington disease presents many challenges for the anesthetist. Of primary importance is that these patients are at increased risk of pulmonary aspiration. The use of short-acting anesthetic drugs should, therefore, be advantageous in promoting the rapid return of protective airway reflexes. We report the first documented use, to date, of propofol and remifentanil total intravenous anesthesia in a patient with Huntington disease and demonstrate its efficacy and safety.
MacPherson
Peter
P
Department of Anaesthesiology, Dr. Grays Hospital, Elgin, Morayshire, Scotland, UK. petermcpherson@talk21.com
Harper
Ian
I
MacDonald
Iain
I
D000328:Adult; D000771:Anesthesia, Intravenous; D019162:Anesthetics, Combined; D017558:Elective Surgical Procedures; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000150:complications*; D010880:Piperidines; D015742:Propofol; D000077208:Remifentanil
D019162:Anesthetics, Combined; D010880:Piperidines; D000077208:Remifentanil; D015742:Propofol